Curaleaf Laboratories and Sanity Group Announce Partnership to Advance Medical Cannabis Innovation in the UK
London, UK – 26th February 2026 — Curaleaf Laboratories, one of the UK-leading pharmaceutical-grade medical cannabis manufacturers, is delighted to announce a partnership with Berlin-based Sanity Group, a European life science company focused on cannabinoids and wellbeing products. The partnership brings together Curaleaf Laboratories’ established manufacturing, quality, and commercial capabilities with Sanity Group’s international expertise […]
Alternative Delivery Systems Beyond Oils & Flower – Curaleaf Laboratories & MCCS Webinar
Curaleaf Laboratories, a leading UK manufacturer of medical cannabis products, is teaming up with the Medical Cannabis Clinicians Society (MCCS) to present a timely and insightful webinar titled “Alternative Delivery Systems: Beyond Oils and Flower.” This event is designed to support healthcare professionals in understanding the expanding landscape of cannabis-based medicinal products (CBPMs) and the latest advancements in their […]
Medical Cannabis is Regulated Medicine
Over the weekend, a media outlet published a story about medical cannabis that, unfortunately, missed key facts about how this medicine is accessed and regulated in the UK. Sensational headlines implying that high-strength cannabis products are easily obtainable with a single consultation without meaningful oversight, risks spreading misinformation that does a disservice to patients, clinicians […]
Curaleaf Laboratories Enters Strategic Partnership with ANTG to Manufacture and Distribute Medicinal Cannabis Products in the UK
London, UK – 12th November, 2025 – Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of products […]
Seven years of progress since UK medical cannabis legalisation
Seven years ago this month, medical cannabis became legal in the UK — a feat hard won by families and advocates who had experienced the life-changing potential of cannabis-based treatments. Since then, the regulations have remained largely unchanged, but what’s grown around them is extraordinary: a sector built by clinicians, scientists, manufacturers and advocates determined […]
Curaleaf Laboratories Partners with the Medical Cannabis Clinicians Society
Championing Clinician Education At Curaleaf Laboratories, we believe that education is the cornerstone of progress in the medical cannabis space. That’s why we’ve proudly partnered with the Medical Cannabis Clinicians Society (MCCS) to further our shared mission: empowering clinicians with credible, practical education on cannabis-based medicines. Clinician education is such a vital part of our […]
Curaleaf Laboratories Launches First Certified Liquid Medical Cannabis Inhaler for UK Patients
The Curaleaf Que Medical Inhalation Device offers precise and consistent administration of cannabis-based medicines 1st September 2025 – Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, […]
Curaleaf Laboratories partners with Dalgety Ltd to distribute UK-grown EU-GMP medical cannabis flowers
Curaleaf Laboratories can today announce a partnership agreement has been reached with Dalgety Ltd, to exclusively manufacture and distribute medical cannabis API produced from their state-of-the-art cultivation facility in the UK. Dalgety, based in Derbyshire, are the first domestic cultivator of medical cannabis to hold EU-GMP licenses for the cultivation and supply of medical cannabis […]